Skip to content

Stereotaxis STXS Free cash flow

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Stryker logo
StrykerSYK
$415M+227%
ITG
Integer HoldingsITGR
$737K-87.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's free cash flow?
Stereotaxis (STXS) reported free cash flow of -$3.52M in Q1 2026.
What is the long-term trend for Stereotaxis's free cash flow?
Over 2 years (2021 to 2023), Stereotaxis's free cash flow has grown at a 47.9% compound annual growth rate (CAGR), from -$4.34M to -$9.51M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.